CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 205 filers reported holding CHEMOCENTRYX INC in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $364,000 | +9.0% | 7,034 | -46.6% | 0.00% | 0.0% |
| Q1 2022 | $334,000 | +25.6% | 13,161 | +79.6% | 0.00% | 0.0% |
| Q4 2021 | $266,000 | +88.7% | 7,326 | -30.4% | 0.00% | – |
| Q2 2021 | $141,000 | -60.9% | 10,523 | +49.4% | 0.00% | -100.0% |
| Q1 2021 | $361,000 | -34.1% | 7,042 | -20.4% | 0.00% | -50.0% |
| Q4 2020 | $548,000 | +13.7% | 8,844 | +0.5% | 0.00% | 0.0% |
| Q3 2020 | $482,000 | -4.7% | 8,800 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $506,000 | +42.9% | 8,800 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $354,000 | +0.9% | 8,800 | -0.8% | 0.00% | 0.0% |
| Q4 2019 | $351,000 | – | 8,875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |